Interactive Investor

The Week Ahead: Diageo, GSK, Shell, BT

Some of the country’s biggest companies report results in the coming days, and investors must keep a close eye on the commentary. Here are the key dates for your diary.

26th January 2024 13:37

Richard Hunter from interactive investor

Monday 29 January

Trading statements

Team Internet Group

AGM/EGM

Hollywood Bowl, Landore Resources 

Tuesday 30 January

Trading statements

Diaceutics, Diageo (LSE:DGE), Kromek, Luceco, Oxford Cannabinoid Technologies, Pets at Home, Renewi, Saga, SSP Group, SThree, Synthomer

AGM/EGM

AJ Bell, Auction Technology Group, Mineral & Financial Investments, Ora Technology, Renew Holdings, SSP Group, Webis Holdings, Valereum 

Wednesday 31 January

Trading statements

Aberforth Smaller Companies Trust, abrdn Private Equity Opportunities Trust, Ecora Resources, GSK (LSE:GSK), ITM Power, NWF Group

AGM/EGM

Imperial Brands, Schroder Asia Pacific Fund, Smiths News

Thursday 1 February

Companies scheduled to begin trading without the right to the latest dividend include Paragon Banking Group and PayPoint.

Trading statements

Airtel Africa, AG Barr, BT Group (LSE:BT.A), Cranswick, Gem Diamonds, Glencore, Rank Group, Shell (LSE:SHEL), TClarke

AGM/EGM

Cerillion, Keystone Positive Change Investment Trust, Sage

Friday 2 February

Trading statements

Nothing in the diary yet

AGM/EGM

Critical Metals, Gunsynd

These articles are provided for information purposes only.  Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties.  The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.

Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.